Stock Quote, Chart, News


Symbol Company Name Latest Time Prev Close Latest Price Change $ Change % 52 Wk High 52 Wk Low YTD Chg% Volume
ARGXargenx SE3:24:11 PM103.29101.5-1.79-1.73111.4353.927760.2989168

News

Argenx: This Below-Radar Dutch Company Is A Potential Winner


2018-12-11 11:42

Argenx ( ARGX ) is developing lead drug candidate efgartigimod in three indications - myasthenia gravis ((MG)), primary immune thrombocytopenia ((ITP)), and pemphigus vulgaris ((PV)). The drug, which is an antibody fragment that binds to FcRn (neonatal Fc receptor), is in the lead in MG, hav…... by SeekingAlpha

Profile

Sector: Healthcare

Industry: Biotechnology

Description: argenx SE, along with its subsidiaries is engaged in the bio-technical research on drugs and pharma processes for the treatment of oncological, autoimmune and inflammatory diseases.

© Stockaplus.com, All Right Reversed.

Market data provided by IEX Group Inc. The information provided by Stockaplus.com is not investment advice. Trading and investing in financial markets involves risk. You are responsible for your own investment decisions.

New stock charting and analyzer software coming soon, please stay tuned, if you want to go to old site, click Here.